Pharmaceutical Ads in Journals
Authors: John F. Beary
Journal: Annals of Internal Medicine (1992)

Letters1 October 1992Pharmaceutical Ads in JournalsJohn F. Beary III, MDJohn F. Beary III, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-117-7-616 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editors: It is unfortunate that the Editors of the Annals did not seek the views of the pharmaceutical industry for publication in the same issue as the study by Wilkes and colleagues on prescription drug advertisements (1). Although they are important, the views of Food and Drug Administration (FDA) Commissioner David Kessler and those of Drs. Robert and Suzanne Fletcher comprise only two thirds of the other side of this issue.Advertising and promotion are important aspects of free market economies. After spending an average of $230 million and 10 years to introduce a new product, a company...References1. WilkesDoblinShapiro MBM. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med. 1992;116:912-9. LinkGoogle Scholar2. Relman A. Pharmaceutical advertisements. Interview on "Morning Edition." WAMU FM radio (National Public Radio). 2 June 1992. Google Scholar1. WilkesDoblinShapiro MBM. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med. 1992;116:912-9. LinkGoogle Scholar2. FletcherFletcher RS. Pharmaceutical advertisements in medical journals [Editorial]. 1992;116:951-2. LinkGoogle Scholar1. WilkesDoblinShapiro MBM. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med. 1992;116:912-9. LinkGoogle Scholar1. FletcherFletcher RS. Pharmaceutical advertisements in medical journals [Editorial]. Ann Intern Med. 1992;116:951-2. LinkGoogle Scholar2. . Findings and conclusions of the NCCC project on drug advertising. J Drug Issues. 1974;4:310-2. CrossrefGoogle Scholar1. FletcherFletcher RS. Pharmaceutical advertisements in medical journals [Editorial]. Ann Intern Med. 1992;116:951-2. LinkGoogle Scholar2. HerxheimerCollier AJ. Promotion in the British pharmaceutical industry, 1983-8: a critical analysis of self-regulation. BMJ. 1990;300:307-11. CrossrefMedlineGoogle Scholar1. WilkesDoblinShapiro MBM. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med. 1992;116:912-9. LinkGoogle Scholar2. Kessler D. Addressing the problem of misleading advertising [Editorial]. Ann Intern Med. 1992;116:950-1. LinkGoogle Scholar3. FletcherFletcher RS. Pharmaceutical advertisements in medical journals [Editorial]. Ann Intern Med. 1992;116:951-2. LinkGoogle Scholar4. Drug manufacturers as medical teachers. JAMA. 1892;18:563. [Reprinted in JAMA. 1992;267:2172.] Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Science and Technology Pharmaceutical Manufacturers Association Washington, DC 20005 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByAdvertising in dermatology journals: Journals' and journal editors' policies, practices, and attitudesIndustry guidelines, laws and regulations ignored: quality of drug advertising in medical journalsConflicts between Commercial and Scientific Interests in Pharmaceutical Advertising for Medical JournalsA Survey of Pharmacists' and Pharmacy Students' Attitudes Toward OTC AdvertisingReply 1 October 1992Volume 117, Issue 7Page: 616-618KeywordsDrugsFood and Drug Administration Issue Published: 1 October 1992 PDF DownloadLoading ...